Christopher M. Yea
2018
In 2018, Christopher M. Yea earned a total compensation of $823.9K as Chief Development Officer at Carbylan Therapeutics.
Compensation breakdown
| Bonus | $306,266 |
|---|---|
| Option Awards | $163,031 |
| Salary | $334,567 |
| Other | $20,074 |
| Total | $823,938 |
Yea received $334.6K in salary, accounting for 41% of the total pay in 2018.
Yea also received $306.3K in bonus, $163K in option awards and $20.1K in other compensation.
Rankings
In 2018, Christopher M. Yea's compensation ranked 10,057th out of 14,244 executives tracked by ExecPay. In other words, Yea earned more than 29.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 10,057 out of 14,244 | 29th |
Division Manufacturing | 4,060 out of 5,765 | 30th |
Major group Chemicals And Allied Products | 1,529 out of 2,128 | 28th |
Industry group Drugs | 1,292 out of 1,817 | 29th |
Industry Pharmaceutical Preparations | 991 out of 1,391 | 29th |
Source: SEC filing on August 25, 2020.
Yea's colleagues
We found two more compensation records of executives who worked with Christopher M. Yea at Carbylan Therapeutics in 2018.